The International Journal of Stroke is the flagship publication of the World Stroke Organization.

Tuesday, October 16, 2018

The ammunition to fight stroke and NCDs together

A Call to Action and Ammunition Needed to Beat
Stroke and NCDs

By Prof Bo Norrving, WSO Global Policy Committee Chair

Next week I will be in
Montréal, alongside 2500 stroke leaders and stakeholders spanning clinical
practice, research, rehabilitation and patient and caregiver organizations. The
expertise and individual interests represented at the biennial World StrokeCongress may be diverse, but our common commitment is the same – to fight
stroke and reduce its devastating impact on individuals and society.

As the world’s second
largest cause of death and disability it is a battle well worth fighting, but
one that we don’t have to – not should we - take on alone. Globallly,
regionally and nationally there are networks and alliances working to break
down the traditional siloes between disease groups in order to increase the
speed at which the world addresses the diseases that are most likely to kill us.
We know, that by connecting the dots and
coordinating our efforts with others who have a shared investment in beating
NCDs, we can achieve more, maximise our investments and move faster than we can
individually. When investments have been slow to come, and governmental commitments
to change continue to disappoint, this could be the key to making progress.

The sense that
together we are stronger, is certainly the driving force for collaboration
between the NCD Alliance and the World Stroke Organization (WSO) and the rationale
behind our latest partnership collaboration Acting on Stroke and NCDs. The aim of this policy brief, which will be launched at
the World Stroke Congress in Montréal, is to clearly articulate the shared
prevention and treatment issues for NCD stakeholders and to set out key
priorities for action at global, regional and national level. It is our hope
that Acting on Stroke and NCDs
provides not just a call to action, but the ammunition needed to beat NCDs.

The publication
clearly sets out the contribution to stroke to global NCD mortality and
identifies the shared and specific gaps in current approaches to addressing stroke
and NCDs. When only 6% of all people who have a stroke have no comorbidities and
when comorbidities result in not only higher healthcare, individual and social
costs, this policy brief sets out a strong evidence-based argument and some
clear action points that will turn the tide on stroke and NCDs .

How to respond to the challenge of stroke and
NCDs

Invest in prevention

Given that 90% of
strokes are linked to 10 modifiable risk factors, several of which are shared
by a number of NCDs, investing human and financial resources in diagnosis,
education and risk reduction will deliver advances across the board

Ensure access to acute and chronic speciality
care

People need to be
treated in services and by clinicians in accordance with clinical practice
guidelines for NCDs. Access to stroke units and to acute therapies is a
backbone in stroke care, as is rehabilitation and long-term support.

Strengthen the primary healthcare network

Access to a solid
primary care network is essential to effective prevention and long-term treatment
of stroke and NCD. Financial barriers and out of pocket costs for prevention,
diagnosis and treatment needs to be reduced. Universal health coverage should cover
essential diagnostic and treatment.

Implement the WHO HEARTS Technical package

Taking the seven steps
set out in this package would ensure that the right medicine reaches stroke
patients at the right time and at an affordable rate.

Every 2 seconds,
someone somewhere in the world has a stroke, the clock is ticking and we don’t
have time to wait – strengthened actions on stroke and NCDs are urgently needed.
Let’s gather our allies, target our actions and work for upscaled efforts. We
have had ENOUGH on political inertia on NCDs.

Top Menu

Main Menu

Social Media Icons

World Stroke Campaign

[Featured][slider][#58ab27]

Translate

Review Policy

IJS adheres to COPE: CODE OF CONDUCT AND BEST PRACTICE GUIDELINES FOR JOURNAL EDITORS.

We publish: Research papers, Reviews, Short Reports, Leading Opinions, Guidelines, Protocols, Panorama, and Editorials. We do not review Leading opinions; Guidelines, unless otherwise advised or submitted without a statement of endorsement from a reputable society; Consensus unless otherwise advised or submitted without a statement of endorsement from a reputable society; and Panorama articles that are about the experience of the author, unless the experience cannot be validated.